Results 131 to 140 of about 44,755 (204)

Modeling response to high-purity von Willebrand factor: toward tailored dosing during surgery in von Willebrand disease. [PDF]

Blood Adv
Daniel MY, Rauch A, Paris C, Jeanpierre E, Goudemand J, Marichez C, Pradines B, Zawadzki C, Dupont A, Denis CV, Lenting PJ, Susen S, Delavenne X.   +12 more
europepmc   +1 more source

Managing Anesthesia for a Patient With Von Willebrand Disease: A Case Report. [PDF]

Cureus
Singavarapu J, Borodulina G.
europepmc   +1 more source

Allele-selective disruption of pathogenic VWF variants in type 2 von Willebrand disease using CRISPR/Cas9. [PDF]

Blood Adv
Bär I, Groten SA, Barraclough A, Bürgisser PE, van Kwawegen C, Lenting PJ, van Moort I, Eikenboom JCJ, Leebeek FWG, Voorberg J, van den Biggelaar M, Bierings R.   +11 more
europepmc   +1 more source

Conservative Management of Hemoperitoneum Due to a Ruptured Hemorrhagic Ovarian Cyst in Type 3 von Willebrand Disease. [PDF]

Cureus
Mahfoud H, Laaboudi R, Elkhorassani M, Elachhab N, Bargach S.   +4 more
europepmc   +1 more source

Immune Thrombocytopenia and Type 1 von Willebrand Disease in a Patient With a Femoral Fracture: A Case Report. [PDF]

Cureus
Ferreira A, Roberto A.
europepmc   +1 more source

Rewriting the script: gene therapy and genome editing for von Willebrand Disease. [PDF]

Front Genome Ed
Barraclough A, Bär I, van Duijl T, Fijnvandraat K, Eikenboom JCJ, Leebeek FWG, Bierings R, Voorberg J, Trasanidou D.   +8 more
europepmc   +1 more source

Characteristics and posttransplant outcomes of patients with congenital and acquired von Willebrand disease and hemophilia A and with renal transplants. [PDF]

Res Pract Thromb Haemost
Chang IW, Truman M, Yee C, Padrnos L.
europepmc   +1 more source

Type 3 von Willebrand disease in Ethiopia: a comprehensive literature review and report of the first three cases. [PDF]

Thromb J
Arega G, Zewde EB, Said AM, Tesfaye SZ, Tamiru TY, Belisa TK, Ejersa MS, Deress AS.   +7 more
europepmc   +1 more source

Postpartum Acquired Hemophilia A in Two Women With Previously Undiagnosed Carrier Status for von Willebrand Disease Type 2N and Heterozygous p.R854Q Mutation. [PDF]

Haemophilia
Weise M, Klöter T, Keller M, Petros S, Pfrepper C.   +4 more
europepmc   +1 more source

Real-word evidence on healthcare resource use and associated costs in on-demand users of replacement therapies in von Willebrand disease in France: the FORvWARD study. [PDF]

J Comp Eff Res
Polack B, Nerich V, Micallef CM, Trossaërt M, Biron-Andreani C, Bornier N, Chatelanaz C, Favre-Besse F, Beoletto J, Née M, Belhassen M, Lefèvre C, Pouvourville G.   +12 more
europepmc   +1 more source